The Quantellect read.As of Nov 19, 2026, 11 active firms cover CareTrust REIT Inc: 8 rate it Buy or better, 3 sit at Neutral, and 0 rate it Sell or worse, a buy consensus. Targets are tightly clustered, $41.00 to $45.00, so the covering firms are broadly aligned. The average target of $42.88 sits 13% above the current $37.96. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees consensus EPS building from about $0.47 next quarter toward $1.93 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS11 active firms
Buy
Strong Buy00%
Buy873%
Neutral327%
Sell00%
Strong Sell00%
Based on 11 active firms as of Nov 19, 2026 (365-day activity window).
12-MONTH PRICE TARGET
$42.88
+12.9% upside
Average target across 8 active firms as of Nov 19, 2026 vs $37.96 current
Highest Target$45.00
Average Target$42.88
Lowest Target$41.00
Detailed analyst forecasts for CTRE
Showing 1–9 of 9 named analysts shown · 11 active firms in the rating projection
As of Nov 19, 2026, 8 of 11 active firms rate CTRE a Buy (3 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
CTRE EPS & revenue forecast
EPS · NEXT QUARTER
$0.47
Range $0.42 – $0.57 · 3 analysts · +30% YoY
Next period, 3 analysts expect CareTrust REIT Inc. to earn $0.47 a share (range $0.42 – $0.57), versus $0.36 a year earlier. Full-year consensus is $1.81, growing to $1.93 the year after.
REVENUE · NEXT QUARTER
$192.6M
Range $168.4M – $216.7M · 3 analysts · +35% YoY
Revenue is expected to reach $192.6M (range $168.4M – $216.7M), +34.9% year-over-year. Full-year consensus is $629.8M, rising to $838.7M next year.
Top analysts covering CareTrust REIT Inc.
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on CTRE.
#1
Jonathan Hughes
Raymond James · Rank #42
Buy
$39.00+2.7% to target
Overall win rate
52%
+ Follow
#2
John Kilichowski
Wells Fargo · Rank #103
Buy
$44.00+15.9% to target
Overall win rate
50%
+ Follow
#3
Aaron Hecht
JMP Securities · Rank #299
Buy
$44.00+15.9% to target
Overall win rate
47%
+ Follow
#4
Michael Carroll
RBC Capital
Neutral
$43.00+13.3% to target
Coverage
—
+ Follow
#5
JC
Juan C. Sanabria
BMO Capital
Buy
$45.00+18.5% to target
Coverage
—
+ Follow
CTRE stock forecast FAQ
What is CTRE's average 12-month price target?+
The 8 active firms with a live target average $42.88 for CareTrust REIT Inc. over the next 12 months, ranging from a $45.00 high to a $41.00 low, as of Nov 19, 2026.
Is CTRE stock a Buy, Sell or Neutral right now?+
The current consensus is Buy. Of the 11 active firms as of Nov 19, 2026, 8 rate it Buy or Strong Buy, 3 rate it Neutral, and 0 rate it Sell or Strong Sell.
What are the highest and lowest price targets for CTRE?+
The Street-high target is $45.00 (BMO Capital), and the Street-low is $41.00 (JP Morgan). The average of all 8 active-firm targets is $42.88.
How many active Wall Street firms cover CTRE?+
11 active firms have a recognized rating on CareTrust REIT Inc. as of Nov 19, 2026, and 8 active firms carry a live 12-month price target.
Who is the most accurate analyst covering CTRE?+
Among analysts who currently cover CTRE, Jonathan Hughes of Raymond James has the strongest overall Quantellect track record (Rank #42). Their current call is Buy with a $39.00 target.
What is CareTrust REIT Inc.'s projected EPS for next quarter?+
The consensus estimate is $0.47 per share (range $0.42 – $0.57) across 3 analysts. Full-year EPS is projected at $1.81, rising to $1.93 the following year.
How much revenue is CareTrust REIT Inc. expected to report next quarter?+
Consensus revenue is $192.6M (range $168.4M – $216.7M). Full-year revenue is projected at $629.8M, growing to $838.7M next year.
Have analysts been upgrading or downgrading CTRE lately?+
As of Nov 19, 2026, 8 of 11 active firms rate CTRE a Buy (3 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their CTRE calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.